LBA91 TOMAS2: A randomized phase II study from the Italian Sarcoma Group (ISG) of trabectedin plus olaparib (T+O) or trabectedin (T) in advanced, metastatic, or unresectable soft tissue sarcomas (STS) after failure of standard treatments.

Authors :: D'Ambrosio, L.
Merlini, A.
Brunello, A.
Ferraresi, V.
Paioli, A.
Vincenzi, B.
Pantaleo, M.A.
De Pas, T.M.
Gurrieri, L.
Sanfilippo, R.
Buonadonna, A.
Baldi, G.G.
Badalamenti, G.
Marchiò, C.
Pignochino, Y.
Manessi, G.
Aliberti, S.
Dei Tos, A.P.
Stacchiotti, S.
Grignani, G.
Source :: Annals of Oncology. 2023 Supplement 2, Vol. 34, pS1332-S1332. 1p.
Publication Year :: 2023

Full Text Access

Tools